Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sandoz
Pharma
Settlement allows Sandoz to launch Eylea biosimilar in late 2026
Regeneron and Sandoz have resolved patent litigation related to a biosimilar version of Eylea, allowing it to launch in the fourth quarter of 2026.
Kevin Dunleavy
Sep 9, 2025 10:30am
CSL's Venofer finally faces generic competition
Aug 13, 2025 2:06pm
Sandoz pumps $440M into another Slovenia biosimilar plant
Jul 2, 2025 9:10am
Sandoz recalls one lot of cefazolin due to mispackaging
Jun 30, 2025 9:01am
Akeso, AstraZeneca, Ono—Fierce Pharma Asia
May 2, 2025 7:58am
Sandoz has filed a lawsuit against Amgen and its Enbrel patents
Apr 14, 2025 11:20am
